Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Illumina Inc (NASDAQ: ILMN) closed at $119.93 in the last session, down -1.68% from day before closing price of $121.98. In other words, the price has decreased by -$1.68 from its previous closing price. On the day, 1.57 million shares were traded. ILMN stock price reached its highest trading level at $123.65 during the session, while it also had its lowest trading level at $119.04.
Ratios:
We take a closer look at ILMN’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.33. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 1.08 whereas as Long-Term Debt/Eq ratio is at 0.63.
On July 11, 2025, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform but kept the price unchanged to $125.
Citigroup reiterated its Neutral rating for the stock on March 04, 2025, while the target price for the stock was revised from $130 to $90.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 12 ’25 when SCOTT DAVIES bought 323 shares for $122.79 per share.
Gottlieb Scott bought 500 shares of ILMN for $61,065 on Nov 03 ’25. The Director now owns 12,523 shares after completing the transaction at $122.13 per share. On May 12 ’25, another insider, Dhingra Ankur, who serves as the SVP, Chief Financial Officer of the company, bought 6,100 shares for $81.21 each. As a result, the insider paid 495,381 and bolstered with 24,906 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ILMN now has a Market Capitalization of 18325303296 and an Enterprise Value of 19614595072. As of this moment, Illumina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.87, and their Forward P/E ratio for the next fiscal year is 23.96. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.28 while its Price-to-Book (P/B) ratio in mrq is 7.71. Its current Enterprise Value per Revenue stands at 4.574 whereas that against EBITDA is 16.808.
Stock Price History:
The Beta on a monthly basis for ILMN is 1.45, which has changed by -0.11195856 over the last 52 weeks, in comparison to a change of 0.1476624 over the same period for the S&P500. Over the past 52 weeks, ILMN has reached a high of $153.06, while it has fallen to a 52-week low of $68.70. The 50-Day Moving Average of the stock is 17.11%, while the 200-Day Moving Average is calculated to be 27.82%.
Shares Statistics:
According to the various share statistics, ILMN traded on average about 1.68M shares per day over the past 3-months and 2472080 shares per day over the past 10 days. A total of 153.00M shares are outstanding, with a floating share count of 148.54M. Insiders hold about 2.79% of the company’s shares, while institutions hold 102.05% stake in the company. Shares short for ILMN as of 1761868800 were 6726492 with a Short Ratio of 4.00, compared to 1759190400 on 6607099. Therefore, it implies a Short% of Shares Outstanding of 6726492 and a Short% of Float of 6.87.
Earnings Estimates
The market rating for Illumina Inc (ILMN) is a result of the insights provided by 15.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $1.11, with high estimates of $1.2 and low estimates of $1.02.
Analysts are recommending an EPS of between $4.79 and $4.66 for the fiscal current year, implying an average EPS of $4.71. EPS for the following year is $4.99, with 20.0 analysts recommending between $5.19 and $4.71.
Revenue Estimates
According to 13 analysts,. The current quarter’s revenue is expected to be $1.1B. It ranges from a high estimate of $1.12B to a low estimate of $1.09B. As of. The current estimate, Illumina Inc’s year-ago sales were $1.1BFor the next quarter, 13 analysts are estimating revenue of $1.06B. There is a high estimate of $1.08B for the next quarter, whereas the lowest estimate is $1.04B.
A total of 16 analysts have provided revenue estimates for ILMN’s current fiscal year. The highest revenue estimate was $4.31B, while the lowest revenue estimate was $4.27B, resulting in an average revenue estimate of $4.29B. In the same quarter a year ago, actual revenue was $4.37BBased on 18 analysts’ estimates, the company’s revenue will be $4.37B in the next fiscal year. The high estimate is $4.41B and the low estimate is $4.31B.
